LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

Search

AngioDynamics Inc

Closed

Sector Healthcare

5.64 -4.08

Overview

Share price change

24h

Current

Min

5.64

Max

5.91

Key metrics

By Trading Economics

Income

-75M

-29M

Sales

-3.9M

75M

P/E

Sector Avg

51.876

23.904

EPS

-0.16

Profit margin

-36.736

EBITDA

2.7M

-247K

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+149.07 upside

Dividends

By Dow Jones

Next Earnings

10 lip 2024

Market Stats

By TradingEconomics

Market Cap

-2.4M

278M

Previous open

9.72

Previous close

5.64

News Sentiment

By Acuity

50%

50%

124 / 370 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

AngioDynamics Inc Chart

Related News

4 kwi 2024, 14:56 UTC

Earnings
Major Market Movers

AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System

Peer Comparison

Price change

AngioDynamics Inc Forecast

Price Target

By TipRanks

149.07% upside

12 Months Forecast

Average 14.67 USD  149.07%

High 18 USD

Low 12 USD

Based on 3 Wall Street analysts offering 12 month price targets forAngioDynamics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 6.52Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

124 / 370 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AngioDynamics Inc

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.